Literature DB >> 16622388

Tranexamic acid for hemostasis in the surgical treatment of metastatic tumors of the spine.

Drew A Bednar1, Vasiliki A Bednar, Ali Chaudhary, Forough Farrokhyar, Forough Farroukhyar.   

Abstract

STUDY
DESIGN: This is a retrospective study of sequential cohorts.
OBJECTIVE: To assess the efficacy of tranexamic acid in decreasing operative blood loss and the need for intraoperative transfusion in metastatic spine surgery. SUMMARY OF BACKGROUND DATA: Significant published data have established the efficacy of antifibrinolytic drugs in limiting surgical bleeding during heart surgery and total joint replacement. One study in scoliosis suggested benefit in spine surgery as well.
METHODS: During a 6-month trial period, 14 patients with spine cancer undergoing palliative intralesional tumor excision and concomitant instrumentation to stabilize the spine in the hands of a single surgeon were administered tranexamic acid intraoperatively in the attempt to minimize operative blood loss. They were then compared to the immediately preceding 14 patients.
RESULTS: Estimated operative blood loss was 1385 mL in the study group treated with tranexamic acid and 1815 mL in controls not receiving the drug, and was not found to be significantly decreased in this study.
CONCLUSIONS: Control of operative bleeding in metastatic spine surgery can be problematical. Optimum protocol might include routine preoperative angiographic tumor embolization to decrease lesion vascularity in all cases, but angiography is not without risk. Noninvasive prophylaxis of tumor bleeding would have obvious desirable advantages but was, unfortunately, not achieved in this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622388     DOI: 10.1097/01.brs.0000209304.76581.c5

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  7 in total

Review 1.  Efficacy and Safety of Tranexamic Acid in Cancer Surgery. An Update of Clinical Findings and Ongoing Research.

Authors:  Tamara Zec; Raffaela Di Napoli; Lydwine Fievez; Mohamed Ben Aziz; Alessandro Ottaiano; Alessandro Vittori; Francesco Perri; Marco Cascella
Journal:  J Multidiscip Healthc       Date:  2022-07-05

Review 2.  The use of tranexamic acid in spine surgery.

Authors:  Joon S Yoo; Junyoung Ahn; Sailee S Karmarkar; Eric H Lamoutte; Kern Singh
Journal:  Ann Transl Med       Date:  2019-09

3.  Hemipelvectomy- only a salvage therapy?

Authors:  Christian Wedemeyer; Max Daniel Kauther
Journal:  Orthop Rev (Pavia)       Date:  2011-03-17

4.  Does tranexamic acid reduce blood loss during head and neck cancer surgery?

Authors:  Atul P Kulkarni; Devendra A Chaukar; Vijaya P Patil; Rajendra B Metgudmath; Rohini W Hawaldar; Jigeeshu V Divatia
Journal:  Indian J Anaesth       Date:  2016-01

Review 5.  Systematic review and meta-analysis of perioperative intravenous tranexamic acid use in spinal surgery.

Authors:  Baohui Yang; Haopeng Li; Dong Wang; Xijing He; Chun Zhang; Pinglin Yang
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

6.  Use of Tranexamic Acid (TXA) on reducing blood loss during scoliosis surgery in Chinese adolescents.

Authors:  Bobby K W Ng; W W Chau; Alec L H Hung; Anna Cn Hui; Tze Ping Lam; Jack C Y Cheng
Journal:  Scoliosis       Date:  2015-10-05

Review 7.  Systemic and Topical Use of Tranexamic Acid in Spinal Surgery: A Systematic Review.

Authors:  Sebastian F Winter; Carlo Santaguida; Jean Wong; Michael G Fehlings
Journal:  Global Spine J       Date:  2015-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.